Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Resources Zizhu Pharmaceutical is a leading Chinese pharmaceutical company specializing in reproductive health drugs and devices, oral drugs, ophthalmic drugs, diabetic medications, and active pharmaceutical ingredients. It is the largest research and production base for family planning medicines in China. Several of its products are approved for use domestically and internationally; it has supplied reproductive health drugs to the United Nations Population Fund since 2014. Its manufacturing site is WHO-prequalified for several finished pharmaceutical products including misoprostol.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Resources Zizhu Pharmaceutical.